Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2336805 in chronic hepatitis C
NCT01439373Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of samatasvir in hepatitis C (HCV), sponsored by GSK. Started Jul 2011; status: completed.
02
Drugs
samatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01439373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439373.